1. Home
  2. INAB vs CISO Comparison

INAB vs CISO Comparison

Compare INAB & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.28

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Logo CISO Global Inc.

CISO

CISO Global Inc.

HOLD

Current Price

$0.22

Market Cap

13.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
INAB
CISO
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
13.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
INAB
CISO
Price
$1.28
$0.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
69.5K
142.6K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.31
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$0.20
52 Week High
$2.73
$1.48

Technical Indicators

Market Signals
Indicator
INAB
CISO
Relative Strength Index (RSI) 53.29 33.05
Support Level $1.17 $0.21
Resistance Level $1.50 $0.32
Average True Range (ATR) 0.09 0.02
MACD 0.03 -0.00
Stochastic Oscillator 81.61 30.97

Price Performance

Historical Comparison
INAB
CISO

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity compliance and is a software firm composed of trained and seasoned security professionals. The services are used to protect clients' data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in the U.S., Chile, and all other countries. The maximum revenue is generated from the U.S. The products and services include: security managed services, professional services, and cybersecurity software.

Share on Social Networks: